Treatment with oxandrolone and the durability of effects in older men
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
We investigated the effects of the anabolic androgen, oxandrolone, on lean body mass (LBM), muscle size, fat, and maximum voluntary muscle strength, and we determined the durability of effects after treatment was stopped. Thirty-two healthy 60- to 87-yr-old men were randomized to receive 20 mg oxandrolone/day ( n = 20) or placebo ( n = 12) for 12 wk. Body composition [dual-energy X-ray absorptiometry (DEXA), magnetic resonance imaging, and 2 H 2 O dilution] and muscle strength [1 repetition maximum (1 RM)] were evaluated at baseline and after 12 wk of treatment; body composition (DEXA) and 1-RM strength were then assessed 12 wk after treatment was discontinued ( week 24). At week 12, oxandrolone increased LBM by 3.0 ± 1.5 kg ( P < 0.001), total body water by 2.9 ± 3.7 kg ( P = 0.002), and proximal thigh muscle area by 12.4 ± 8.4 cm 2 ( P < 0.001); these increases were greater ( P < 0.003) than in the placebo group. Oxandrolone increased 1-RM strength for leg press by 6.7 ± 6.4% ( P < 0.001), leg flexion by 7.0 ± 7.8% ( P < 0.001), chest press by 9.3 ± 6.7% ( P < 0.001), and latissimus pull-down exercises by 5.1 ± 9.1% ( P = 0.02); these increases were greater than placebo. Oxandrolone reduced total (-1.9 ± 1.0 kg) and trunk fat (-1.3 ± 0.6 kg; P < 0.001), and these decreases were greater ( P < 0.001) than placebo. Twelve weeks after oxandrolone was discontinued ( week 24), the increments in LBM and muscle strength were no longer different from baseline ( P > 0.15). However, the decreases in total and trunk fat were sustained (-1.5 ± 1.8, P = 0.001 and -1.0 ± 1.1 kg, P < 0.001, respectively). Thus oxandrolone induced short-term improvements in LBM, muscle area, and strength, while reducing whole body and trunk adiposity. Anabolic improvements were lost 12 wk after discontinuing oxandrolone, whereas improvements in fat mass were largely sustained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 1×
“Both crosssectional (15, 28, 51) and longitudinal (17, 30) studies have shown that serum total and free concentrations of testosterone decline with advancing age in men.”
BackgroundHigh-Intensity Strength Training in Nonagenarians: Effects on Skeletal Muscle
Fiatarone, M. A. (1990) · JAMA · doi:10.1001/jama.1990.03440220053029 · Cited by 1,593 · cited 1×
“However, older adults typically produce their best performance (highest force production) on the second or third 1-RM trial (12, 40).”
BackgroundAging of skeletal muscle: a 12-yr longitudinal study
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & Roubenoff, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1321 · Cited by 1,443 · cited 1×
“ADVANCING AGE IS ASSOCIATED with a progressive loss of muscle mass (sarcopenia), skeletal muscle strength, and physical function (1, 2, 9, 14, 19).”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“These observations suggest that the formulation and potency of the androgen, dose, and duration of therapy may affect the changes in lean tissue achieved, which is in keeping with a recent dose ranging study of testosterone in younger men (5).”
ResultSelf-citationAppendicular skeletal muscle mass: effects of age, gender, and ethnicity
Gallagher, D., Visser, M., De Meersman, R. E., Sepúlveda, D., Baumgartner, R. N., Pierson, R. N., Harris, T., & Heymsfield, S. B. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.229 · Cited by 966
Leg extensor power and functional performance in very old men and women.
Bassey, E. J., Fiatarone, M. A., O'neill, E. F., Kelly, M., Evans, W. J., & Lipsitz, L. A. (1992) · Clinical Science · doi:10.1042/cs0820321 · Cited by 943 · cited 1×
“ADVANCING AGE IS ASSOCIATED with a progressive loss of muscle mass (sarcopenia), skeletal muscle strength, and physical function (1, 2, 9, 14, 19).”
BackgroundMorley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Predictors of skeletal muscle mass in elderly men and women
Baumgartner, R. N., Waters, D. L., Gallagher, D., Morley, J. E., & Garry, P. J. (1999) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00130-4 · Cited by 809 · cited 1×
“There is some evidence that bioavailable testosterone levels (free and the fraction loosely bound to albumin) correlate with skeletal muscle mass and muscle strength in different ethnic populations (3, 35).”
BackgroundKatznelson, L., Finkelstein, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., & Klibanski, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954042 · Cited by 791 · cited 2×
“Testosterone treatment in hypogonadal young men increases lean tissue (4, 7, 20, 45, 53, 54) and muscle strength (4, 54) and decreases fat mass (4, 20, 54).”
BackgroundEffects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768
Research works printed but not linked: 31
- 10.1093/oxfordjournals.aje.a009520 · DOI · Paper page
- Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, Lee WP, Bunnell TJ, and Casaburi R. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 82: 407-413, 1997. · DOI · Paper page
- 10.1016/S0303-7207(01)00414-2 · DOI
- 10.1001/jama.285.19.2486 · DOI · Paper page
- Fleck S and WJK. Designing resistance training programs. In: Human Kinetics (2nd ed.). Champaign, IL: Human Kinetics, 1997, p. 4, 98–100.
- 10.1002/bms.1200040205 · DOI · Paper page
- 10.1210/jc.2002-020918 · DOI
- 10.1093/gerona/50A.Special_Issue.1 · DOI · Paper page
- 10.3109/07435800009066159 · DOI · Paper page
- 10.1002/j.1550-8528.1995.tb00197.x · doi:10.1002/j.1550-8528.1995.tb00197.x
- 10.1113/jphysiol.1983.sp014658 · DOI · Paper page
- 10.1002/(SICI)1097-0142(19970501)79:9<1828::AID-CNCR28>3.0.CO;2-Z · doi:10.1002/(sici)1097-0142(19970501)79:9<1828::aid-cncr28>3.0.co;2-z
- 10.1111/j.1532-5415.1993.tb02049.x · DOI · Paper page
- 10.1046/j.1365-201X.1996.483230000.x · DOI · Paper page
- 10.1042/bj2760559 · DOI
- 10.1001/jama.279.21.1720 · DOI · Paper page
- 10.1053/meta.2000.7710 · DOI · Paper page
- 10.1111/j.1532-5415.2000.tb04717.x · DOI · Paper page
- 10.1001/jama.285.19.2481 · DOI · Paper page
- 10.1123/japa.10.4.489 · DOI
- 10.1152/ajpendo.00189.2002 · DOI
- 10.1210/jcem.82.6.3988 · DOI · Paper page
- Snyder PJ, Peachey H, Berlin JA, Hannoush P, Haddad G, Dlewati A, Santanna J, Loh L, Lenrow DA, Holmes JH, Kapoor SC, Atkinson LE, and Strom BL. Effects of testosterone replacement in hypogonadal men. J Clin Endocrinol Metab 85: 2670-2677, 2000. · DOI · Paper page
- Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, and Strom BL. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84: 2647-2653, 1999. · DOI · Paper page
- 10.1210/jc.2002-021231 · DOI · Paper page
- 10.1001/jama.281.14.1282 · DOI · Paper page
- 10.1210/jcem.86.8.7782 · DOI
- 10.1016/S0950-351X(98)80153-5 · DOI
- Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, Steiner B, Hull L, Callegari C, and Swerdloff RS. Testosterone replacement therapy improves mood in hypogonadal men–a clinical research center study. J Clin Endocrinol Metab 81: 3578-3583, 1996. · doi:10.1210/jcem.81.10.8855804 · Paper page
- 10.1210/endo-128-1-379 · DOI · Paper page
- 10.1002/bms.1200211004 · DOI · Paper page
Cited by
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Testosterone and Growth Hormone Improve Body Composition and Muscle Performance in Older Men
Sattler, F. R., Castaneda-Sceppa, C., Binder, E. F., Schroeder, E. T., Wang, Y., Bhasin, S., Kawakubo, M., Stewart, Y., Yarasheski, K. E., Ulloor, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2338 · Cited by 194
Self-citationSarcopenic obesity: how do we treat it?
Bouchonville, M. F., & Villareal, D. T. (2013) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/01.med.0000433071.11466.7f · Cited by 141
O'Connell, M. D. L., Roberts, S. A., Srinivas-Shankar, U., Tajar, A., Connolly, M. J., Adams, J. E., Oldham, J. A., & Wu, F. C. W. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1167 · Cited by 98
“The effects of 12-week treatment with the anabolicandrogenic steroid, oxandrolone, on muscle mass and strength in healthy elderly men were shown to decline within 12 weeks of treatment cessation (16).”
BackgroundResultStorer, T. W., Miciek, R., & Travison, T. G. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.104 · Cited by 70
Metadata
- Authors
- Schroeder, E. T., Zheng, L., Yarasheski, K. E., Qian, D., Stewart, Y., Flores, C., Martinez, C., Terk, M., & Sattler, F. R.
- Venue
- Journal of Applied Physiology
- Publisher
- American Physiological Society
- Published
- 2004-03
- Volume
- 96
- Issue
- 3
- Pages
- 1055-1062
- ISSN
- 0161-7567 (ISSN-L)
- 8750-7587
- 1522-1601
- OpenAlex
- W2149311704
- Cited by
- 40
- References
- 23
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment with oxandrolone and the durability of effects in older men. https://app.cochat.ai/papers/10.1152/japplphysiol.00808.2003
- The paper
- Schroeder, E. T., Zheng, L., Yarasheski, K. E., Qian, D., Stewart, Y., Flores, C., Martinez, C., Terk, M., & Sattler, F. R. (2004). Treatment with oxandrolone and the durability of effects in older men. Journal of Applied Physiology. https://doi.org/10.1152/japplphysiol.00808.2003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.